A Study of BAX 888 in Male Adults With Severe Hemophilia A

NCT03370172 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: BAX 888

Sponsor

Baxalta now part of Shire

Collaborators

[object Object]
[object Object]